Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-08-06

Clinical Trial Update: Comparison of SoloSTAR With a Syringe-administered Glargine Insulin in Diabetic Patients From the Hospital [Phase 4]

View source ↗

Summary

Phase 4 trial comparing SoloSTAR with syringe-administered glargine insulin in diabetic patients; completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SoloSTAR
  • glargine insulin (insulin glargine)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Diabetes | Phase 4 | Status: COMPLETED | Results posted: 2021-08-06